TY  - GEN
AU  - Gore,S D
AU  - Rowinsky,E K
AU  - Miller,C B
AU  - Griffin,C
AU  - Chen,T L
AU  - Borowitz,M
AU  - Donehower,R C
AU  - Burks,K L
AU  - Armstrong,D K
AU  - Burke,P J
AU  - Grever,M R
AU  - Kaufmann,S H
TI  - A phase II "window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia
SN  - 1078-0432
PY  - 1999///0223
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Bone Marrow
KW  - drug effects
KW  - DNA Topoisomerases, Type I
KW  - metabolism
KW  - Female
KW  - Humans
KW  - Leukocyte Count
KW  - Male
KW  - Middle Aged
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - drug therapy
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - antagonists & inhibitors
KW  - Risk Factors
KW  - Topoisomerase I Inhibitors
KW  - Topotecan
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S
ER  -